| Product Name | Benzoylaconine |
|---|---|
| CAS | 466-24-0 |
| Formula | C32H45NO10 |
| MW | 603.7 |
| Appearance | 白色粉末 |
| Boiling point | 711.4±60.0 °C | Condition: Press: 760 Torr |
| PKa | 11.94±0.70 | Condition: Most Acidic Temp: 25 °C |
| Product Name | Benzoylaconine |
|---|---|
| CAS | 466-24-0 |
| Formula | C32H45NO10 |
| MW | 603.7 |
| Appearance | 白色粉末 |
| Boiling point | 711.4±60.0 °C | Condition: Press: 760 Torr |
| PKa | 11.94±0.70 | Condition: Most Acidic Temp: 25 °C |
WKQ-0000084
中文名稱：苯甲酰烏頭原堿
中文別名：苯甲酰烏頭堿
英文名稱：Benzoylaconine
英文別名：Picraconitine (8CI);11aH-12,3,6a-Ethanylylidene-7,9-methanonaphth[2,3-b]azocine, aconitane-3,8,13,14,15-pentol deriv.;14-Benzoylaconine;14-O-Benzoylaconine;Aconine 14-benzoate;Benzaconine;Benzoylaconine;Isaconitine;Pikraconitin;
分子式：C32H45NO10
分子量：603.70
CAS號(hào)：466-24-0
純度：HPLC≥98%
沸點(diǎn)：711.4±60.0 °C | Condition: Press: 760 Torr
密度：1.40±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度數(shù)：11.94±0.70 | Condition: Most Acidic Temp: 25 °C
儲(chǔ)存條件：-20℃，干燥、避光、密封
規(guī)格：5mg10mg20mg50mg100mg500mg1g2g等應(yīng)客戶需求包裝
供應(yīng)單位：四川省維克奇生物科技有限公司
供應(yīng)電話：028-81700200/4008005713
四川省維克奇生物科技有限公司生產(chǎn)中藥類標(biāo)準(zhǔn)品和天然植物有效單體，主打中藥對(duì)照品/標(biāo)準(zhǔn)品/天然植物有效單體，化學(xué)合成，抗生素三大板塊。公司推出丹參系列、龍膽系列、蟲(chóng)草系列等，敬請(qǐng)關(guān)注！ 新批次有現(xiàn)貨，歡迎咨詢。
| Components and Pharmacodynamical Mechanism of Yinfupian Based on Liquid Chromatography-Mass Spectrometry and Proteomics Analyses | ||
| Source:SCI：Frontiers in Pharmacology | Author:Tong Heng-li | Notes：影響因子：5.811 |
| Reference description | ||
Standard solution: All standards (Weikeqi biotech Co., Ltd., Chengdu, China) were weighed and added isopropanol-dichloromethane (1:1) mixed solution to prepare solution contained 10.32 μg/ml aconitine (Batch NO. 130723), 37.38 μg/ml mesaconitine (Batch NO.130402), 5.75 μg/ml hypaconitine (Batch NO. 130509), 33.34 μg/ml benzoylaconine (Batch NO. 130516), 7.92 μg/ml benzoylmesaconine (Batch NO. 130505), and 5.38 μg/ml benzoylhypaconine (Batch NO. 130401). | ||
| Material Basis of Chinese Herbal Formulas Explored by Combining Pharmacokinetics with Network Pharmacology | ||
| Source:SCI：PLoS One | Author:Lixia Pei | Notes：影響因子：3.73 |
| Reference description | ||
Fifteen standard compounds (psoralen, isopsoralen, corylifolin, corylifolinin, psoralidin, xanthotoxin, bergapten, osthole, imperatorin, aconitine, hypaconitine, mesaconitine, benzoylaconine, benzoylhypaconine, and benzoylmesaconitine; Figure 1), were purchased from Weikeqi Biological Technology Co., Ltd. (Chengdu, China). The purities of the compounds were >98% as determined by high-performance liquid chromatography (HPLC). The stock solution of each standard was prepared at a concentration of 1 mg/mL in 50% MeOH and stored at ?80°C until use. | ||
| Optimization of the traditional processing method for precision detoxification of CaoWu through biomimetic linking kinetics and human toxicokinetics of aconitine as toxic target marker | ||
| Source:SCI：JOURNAL OF ETHNOPHARMACOLOGY | Author:Han Qing Li | Notes：影響因子：3.414 |
| Reference description | ||
AC (purity?≥?98%, lot: 20160514) was purchased from Baoji Herbest Bio-Tech Co., Ltd (Xi'an, China) and benzoylaconine (BAC) (purity?≥?98%, lot: 140316) was purchased from Cheng Du WeiKeQi-Bio-Tech Co., Ltd (Sichuan, China). Deionized water in the entire study was purified on a Milli-Q system | ||
| Human intestine and liver microsomal metabolic differences between C19-diester and monoester diterpenoid alkaloids from the roots of Aconitum carmichaelii Debx. | ||
| Source:SCI：TOXICOLOGY IN VITRO | Author:Min Zhang | Notes：影響因子：2.866 |
| Reference description | ||
BAC, BMA and BHA (purity > 98%) were purchased from Weikeqi Biotechnology Co., Ltd. (Chengdu, Sichuan, China). AC, MA and HA (purity > 98%) were purchased from Meilun Biotechnology Co., Ltd. | ||
| The influence of compatibility of Si-Ni decoction with metabolism in intestinal bacteria on transports of toxic diterpenoid alkaloids from processed aconite root across Caco-2 monolayers | ||
| Source:SCI：JOURNAL OF ETHNOPHARMACOLOGY | Author:Min Zhang | Notes：影響因子：3.115 |
| Reference description | ||
14-O-benzoylmesaconine (PubChem CID 24832659), 14-O-benzoylaconine (PubChem CID 20055771) and 14-O-benzoylhypaconine (PubChem CID 78358526), liquiritin apioside (PubChem CID 10076238), liquiritin (PubChem CID 503737), liquiritigenin (PubChem CID 114829), isoliquiritin apioside (PubChem CID 6442433), isoliquiritin (PubChem CID 5318591), isoliquiritigenin (PubChem CID 638278), glycyrrhizic acid (PubChem CID 14982) and glycyrrhetic acid (PubChem CID 3230) were purchased from Chengdu Weikeqi Biological Technology Co., Ltd. (Chengdu, Sichuan, China). Hypaconitine (PubChem CID 441737), atenolol (PubChem CID 2249) and propranolol hydrochloride (PubChem CID 62882) were purchased from Dalian Meilun Biological Technology Co., Ltd. | ||
